Publications in other proceedings
-
BrazMedChem 2022
Identification of novel chemical starting points for the development of LMTK3 kinase inhibitors
-
BrazMedChem 2022
Expanding the toolbox for MAP2K3 inhibitors
-
BrazMedChem 2022
Development of new chemical tools to investigate the lysosomal TRPML1 ion channel
-
BrazMedChem 2019
Lead-Optimization of 1-(4-aryl)cyclohexyl-4-(3-pyridyl)piperazine as TRPV6 Inhibitors
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
